SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NVS: Novartis AG -- Ignore unavailable to you. Want to Upgrade?

To: Paul Senior who wrote (38)5/21/2001 4:18:32 PM
From: Starlight  Read Replies (2) | Respond to of 116
 
Hi Paul - Watching this stock is like watching paint dry -- but the company seems to have some very exciting new drugs about due to come on the market. I believe Gleevec is now available in wide distribution - or soon will be - and the news about patient results during the trials was very encouraging. We can only hope for more good news in the future -- but I don't know what it's going to take to move this stock. I guess revenue growth is the thing to look for.

Betty



To: Paul Senior who wrote (38)6/1/2001 6:09:15 PM
From: Night Writer  Read Replies (2) | Respond to of 116
 
Paul,
Bought NVS this morning. Found you here this afternoon. Must be a good buy at this point.<G>
NW


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News